News

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
TeamSense reports unplanned absences cost American businesses $600B annually, highlighting patterns to help manage ...
Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...
TeamSense reports unplanned absences cost American businesses $600B annually, highlighting patterns to help manage ...
Flu vaccine as high as 59% effective for children 6 months to 8 years old: CDC The flu and pneumonia are now killing nearly 4,000 Americans each week, according to health official ...